Logo
Chat on WhatsApp

CDSCO License for Ventricular bypass (assistive)

Medical Device Information

Device Class
Class D

Intended Use

A ventricular bypass (assistive) device is a device that assists the left or right  ventricle in maintaining circulatory  blood flow.

Manufacturing License
MD9
Import License
MD15
CDSCO License for Ventricular bypass (assistive)

Comprehensive CDSCO Licensing Guide for Ventricular Bypass (Assistive) Medical Devices

As a trusted regulatory consultancy with over 25 years of experience and having supported 500+ companies, we understand the critical importance of securing the correct CDSCO license for your ventricular bypass (assistive) device. This life-supporting catheter device, classified as Class D due to its high risk, requires rigorous compliance with Indian medical device regulations to ensure patient safety and market access.

Understanding Ventricular Bypass (Assistive) Devices and Regulatory Importance

Ventricular bypass (assistive) devices are sophisticated catheters designed to assist the left or right ventricle in maintaining circulatory blood flow. Given their vital role in cardiac function, these devices fall under the highest risk category (Class D) as per CDSCO's medical device classification [Notification 29/Misc/3/2017-DC (292) dated 06.06.2018]. Comprehensive regulatory oversight ensures these devices meet stringent safety and performance standards before entering the Indian market.

CDSCO Regulatory Framework for Ventricular Bypass (Assistive) Devices

In India, the Central Drugs Standard Control Organization (CDSCO) governs the import and manufacture of medical devices under the Medical Device Rules, 2017. For Class D devices like ventricular bypass catheters, licensing is issued by the Central Licensing Authority. The regulatory framework mandates:

  • Obtaining a Test License (Form MD13) before manufacturing
  • Product testing at CDSCO-approved laboratories
  • Submission of detailed technical and quality documentation
  • Pre-license inspection and audit by CDSCO officials
  • Final grant of Manufacturing License (Form MD9)

The entire process typically spans 4 to 5 months, reflecting the high level of scrutiny for these critical devices.

Risk Classification and License Requirements for Class D Devices

Class D devices are categorized as high-risk due to their direct impact on sustaining life. Consequently, manufacturers must obtain an MD9 license from the CDSCO Central Licensing Authority. This license involves:

  • Application on Form MD7
  • Prior Test License (MD13) application
  • Stringent product testing
  • Comprehensive document and system audits

Our detailed Medical Device Classification guide can help you verify your device's risk category and associated requirements.

Manufacturing License Process for Ventricular Bypass Devices (MD9 License)

  1. Apply for Test License (Form MD13): Submit an application via the CDSCO MD Online Portal to obtain permission for product testing. This phase usually takes 1.5 to 2 months.

  2. Product Testing: Get your ventricular bypass devices tested at government-approved laboratories listed on the CDSCO portal. Testing ensures conformity with Indian standards.

  3. Document Preparation: Compile exhaustive technical documentation including Device Master File (DMF), Plant Master File (PMF), risk management files, and quality management system (QMS) documents.

  4. Submit MD9 License Application (Form MD7): After successful testing, apply for the manufacturing license through the online portal.

  5. CDSCO Inspection: CDSCO inspectors conduct a thorough audit of your manufacturing facility, QMS, and compliance with essential principles.

  6. Query Resolution: Address any observations or queries raised during inspection promptly.

  7. License Grant: Upon satisfactory compliance, the MD9 license is granted, enabling manufacturing of Class D devices.

For a deep dive into the MD9 application process, refer to our MD9 License Guide.

Manufacturing License Documents Required for MD9 Application

The following documents are mandatory:

  • Company Constitution and Incorporation Certificates
  • Proof of Ownership or Lease Agreement of Manufacturing Premises
  • Details and Qualification Documents of Technical Staff
  • Fire Safety and Pollution Control NOCs
  • Device Master File (DMF) detailing design and specifications (Guide here)
  • Plant Master File (PMF) describing manufacturing processes (Guide here)
  • Essential Principles Checklist compliance
  • Risk Management File demonstrating compliance with ISO 14971 (Risk Management Tips)
  • Test Reports from CDSCO-approved laboratories (Testing Labs List)
  • Product labels and Instructions for Use (IFU)
  • Quality Management System (QMS) documentation compliant with ISO 13485

Import License Process for Ventricular Bypass Devices (MD15 License)

For companies importing these devices into India, an Import License (Form MD15) must be obtained from the Central Licensing Authority. Key steps include:

  • Preparing comprehensive documentation including manufacturing license from the country of origin, Free Sale Certificate, CE Certificate, Device and Plant Master Files, and ISO 13485 certification.
  • Applying via the CDSCO MD Online Portal
  • Responding to any departmental queries
  • Awaiting license grant

The import license process typically takes 5 to 6 months, reflecting the rigorous evaluation required for Class D devices. For more details, consult our Import License Guide.

Timeline and Processing Duration

License TypeProcess Duration
Test License (MD13)1.5 - 2 months
MD9 Manufacturing License4 - 5 months (including test license and audit)
MD15 Import License5 - 6 months

Manufacturers should plan their product launch timelines accordingly, factoring in potential query resolutions and audit scheduling.

Government Fees and Costs for MD9 License

  • Application Fee: ₹50,000 per application
  • Product Fee: ₹1,000 per product

These fees are payable through the CDSCO online portal during application submission. Additionally, costs for product testing and notified body audits must be budgeted.

Common Challenges and Practical Solutions

Challenge: Delays in testing due to limited slots at government-approved labs.

Solution: Schedule your testing early and consider multiple approved labs from the Testing Laboratories list to avoid bottlenecks.

Challenge: Non-compliance findings during CDSCO audit.

Solution: Conduct internal pre-audits and maintain robust QMS documentation to ensure readiness.

Challenge: Incomplete or inconsistent documentation leading to query backlogs.

Solution: Work with experienced consultants to prepare and cross-verify all documents according to CDSCO checklists.

Expert Consultation and Support

Navigating the CDSCO licensing pathway for a Class D device can be complex. Our team offers end-to-end regulatory support, from initial device classification and documentation preparation to audit readiness and query management. Leveraging our 25+ years of expertise ensures faster approvals and compliance peace of mind.

Getting Started with Your CDSCO License Application

To initiate your licensing journey for ventricular bypass (assistive) devices:

  1. Visit the CDSCO MD Online Portal and register your organization.
  2. Gather all required documents, prioritizing Device Master File and Plant Master File preparation.
  3. Apply for the Test License (Form MD13) to commence product testing.
  4. Coordinate testing with government-approved laboratories early to optimize timelines.
  5. Begin compiling your MD9 manufacturing license application as testing progresses.

By following this structured approach, manufacturers and importers can efficiently navigate the regulatory maze and bring their critical ventricular bypass devices to Indian patients safely and compliantly.

Get Expert Help

Free consultation for your medical device license

24/7 Support Available

Why Choose Us

500+ Licenses Obtained
100% Success Rate
15+ Years Experience
24/7 Support Available

About the Author

avatar
Tails Azimuth
@Twitter